Oncotarget: New Developments in the Treatment of Breast Cancer

The people who have been diagnosed with breast cancer have something to smile about. The news published by one of the leading journals, known as Oncotarget is music to the ears of these patients. According to Oncotarget, medical professionals will now be able to easily identify and eliminate the cells causing cancer if they have a protein molecule that is known as estrogen receptor beta. Scientists in the medical profession have also announced to the world that they will be targeting several other molecules in the breast to develop the right therapy for the condition that has claimed the lives of so many people. Learn more about Oncotarget at Eurekalert.org.

Cancer has become an international disaster. People, regardless of their age, color or race are losing their lives because they have been diagnosed with the deadly medical conditions. Although technology has made things so easy in the modern times, very little developments have been registered in the cancer department. People, even those with a lot of wealth are losing life just because they cannot get the right treatment for cancer. Oncotarget was started several years ago, and it is giving people information about cancer so that they can understand it more. Follow Oncotarget on Linkedin.

According to popular study that was recently published by the prestigious Impact Journals, the best cancer treatment therapies happen when the disease has been diagnosed in time. The journal states that the cancer of the breast has a host hormone that acts as the receptor of progesterone and estrogen. All these essential hormones are needed for the development and functioning of the cells in the breast. There are several types of breast cancers in the modern times. Out of these numerous types, the triple negative breast cancer, popularly known as TNBC remains to be the most difficult to cure since the breast will not have the receptors needed for therapies to work.

Oncotarget is published by experts in the oncology department, and this is why it has received a lot of support from clients from all over the globe. The papers published in this journal have assisted people from all over the world. Students and patients from the globe can access the journal twice a week.

Know more: https://www.researchgate.net/journal/1949-2553_Oncotarget